Technology Profits Confidential

The world of tech and biotechnology will provide endless opportunity for growth and wealth for investors who know where to look.

Technology Profits Confidential is your one-stop shop for the companies of tomorrow's technology... and how you can profit from them.

Temporary Weakness Sets up Future Returns

I'm getting set for a long drive out of town with Patrick to get the scoop on what's going on at the Roskmap Institute’s laboratories. Roskamp's focus is on diseases of the brain and inflammation-related diseases of aging. One compound under study at the institute is anatabine. Anatabine is a compound found in solanaceous plants like peppers, tomatoes and tobacco. It is already showing evidence of powerful effects in Alzheimer's disease in peer-reviewed research. It is also demonstrating a powerful anti- inflammatory effect. Time is short, so I'll keep this update brief.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Technology Profits Confidential

With new technologies in mobile computing, biotechnology and 3-D printing, it’s nearly impossible to keep up with the throngs of new innovation and still be able to forecast which companies are set to profit. Technology Profits Confidential is your one-stop shop for the companies of tomorrow’s technology… and how you can profit from them.

LoginGet Access

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco